author-photo

Ivana von Metzler

Goethe University Frankfurt

10

Papers

39

Citations

Citation Trend

Filter By

Papers (7) Sort By

Journal Conference Others

Prediction of Early Death and Severe Infections during Novel Agent-Based Induction Therapy in Newly-Diagnosed Multiple Myeloma: An Intergroup Analysis from the German Speaking Myeloma Multicenter Group, the Dutch-Belgian Cooperative Trial Group for Hematology Oncology Foundation and the European Myeloma Network

2021 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Severe impairment of T-cell responses to BNT162b2 immunization in multiple myeloma patients.

2021 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Treatment Patterns and Outcomes in Lenalidomide-Exposed Multiple Myeloma Patients in Real-World Settings: A Multi-Center Retrospective Study

2021 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Safety and Preliminary Efficacy Results from a Phase II Study Evaluating Combined BRAF and MEK Inhibition in Relapsed/Refractory Multiple Myeloma (rrMM) Patients with Activating BRAF V600E Mutations: The GMMG-Birma Trial

2020 Blood
Show All
- Source
- Cite
- Save
Citations (8)
Patterns of Renal Recovery and Toxicity with Novel Agent-Based Induction Triplets in Newly Diagnosed Multiple Myeloma - an Analysis of Two Prospective Studies By the German DSMM Myeloma Study Group

2019 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Clinical Impact of Colonization with Multidrug-Resistant Organisms on Outcome after Autologous Stem Cell Transplantation: A Retrospective Single-Center Study

2017 Biology of Blood and Marrow Transplantation
Show All
- Source
- Cite
- Save
Citations (17)
Lenalidomide, doxorubicin hydrochloride and dexamethasone versus bortezomib, lenalidomide, and dexamethasone prior to scheduled stem cell transplant in newly diagnosed myeloma.

2017 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)